MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC - LYELL IMMUNOPHARMA INC ownership

LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 78 filers reported holding LYELL IMMUNOPHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC ownership history of LYELL IMMUNOPHARMA INC
ValueSharesWeighting
Q3 2021$19,536,000
-99.9%
1,320,0000.0%3.59%
-7.8%
Q2 2021$21,436,800,0001,320,0003.90%
Other shareholders
LYELL IMMUNOPHARMA INC shareholders Q4 2021
NameSharesValueWeighting ↓
MWG Management Ltd. 20,162,332$101,820,00043.09%
Apoletto Ltd 15,093,969$76,225,00020.06%
Foresite Capital Management IV, LLC 13,282,181$67,075,00018.76%
HSG Holding Ltd 3,045,997$15,382,0001.92%
MIC Capital Management UK LLP 1,320,000$6,666,0001.30%
Alphabet Inc. 5,865,125$29,619,0000.96%
Board of Trustees of The Leland Stanford Junior University 1,647,882$8,322,0000.47%
Adero Partners, LLC 253,512$1,280,0000.19%
Artal Group S.A. 700,000$3,535,0000.15%
Eagle Health Investments LP 100,000$505,0000.12%
View complete list of LYELL IMMUNOPHARMA INC shareholders